胰内胆管切除在I型先天性胆管扩张症中的疗效与安全性:多中心对照队列研究
结果显示REC组长期无并发症生存更优(HR=0.08,95%CI 0.04-0.15,P<0.001),再入院、再手术及癌变率更低,Mayo评分更优,而总体围术期并发症及严重胰腺相关并发症无显著差异。结论认为REC是有效且安全的手术方式,应常规推荐。
要点
- REC组长期无并发症生存显著优于SEC组(HR=0.08,P<0.001)。
- REC组再入院、再手术及癌变率更低,Mayo评分更优(P<0.05)。
- 两组总体及严重胰腺相关围术期并发症无显著差异(P>0.05)。
核心结论
- 对于累及胰内胆管的Todani I型先天性胆管扩张症,根治性肝外囊肿切除(含胰内胆管)相比次全切除(保留胰内胆管)可显著改善长期无并发症生存,且不增加严重围术期并发症,应常规推荐。
主要发现
- REC组长期无并发症生存优于SEC组(log-rank P<0.001;HR=0.08,95%CI 0.04-0.15,P<0.001)。
- REC组再入院、再手术及癌变率更低,Mayo评分更优(P<0.05)。
- 两组总体围术期并发症、严重围术期并发症及严重胰腺相关围术期并发症无显著差异(P>0.05)。
- 按年龄亚组分析显示主要和次要结局趋势与总体分析相似。
临床怎么用
- 对于累及胰内胆管的Todani I型先天性胆管扩张症,可优先考虑根治性肝外囊肿切除(含胰内胆管),以降低远期并发症、再入院、再手术及癌变风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the efficacy and safety of radical extrahepatic cyst excision (REC), which includes the intrapancreatic bile duct (IPBD), and subtotal extrahepatic cyst excision (SEC), which preserves the IPBD, in treating Todani type I congenital bile duct dilation with IPBD involvement (I-IPBD). BACKGROUND: The application of REC and SEC in I-IPBD remains debated. METHODS: The multicenter study recruited I-IPBDs who underwent REC or SEC from 5 centers between 2006 and 2024. The primary endpoint was occurrence of long-term complications, including recurrent cholangitis, pancreatitis, and IPBD stones. The secondary outcomes included readmission, reoperation, life quality assessed by Mayo score, carcinogenesis, and perioperative complications categorized as overall, severe, pancreas-related, and severe pancreas-related. RESULTS: Three hundred fifty-five I-IPBDs were included and divided into the REC group (175 cases) and SEC (180 cases) from 722 type I congenital bile duct dilations. The REC group demonstrated better long-term complication-free survival compared with SEC group (log-rank P < 0.001; hazard ratio = 0.08, 95% CI: 0.04-0.15, P < 0.001). The REC group had lower rates of readmission, reoperation, and carcinogenesis, and achieved a superior Mayo score ( P < 0.05). No significant differences were observed between the REC and SEC groups in overall perioperative complications, severe perioperative complications, and severe pancreas-related perioperative complications ( P > 0.05). Furthermore, subgroup analysis by age demonstrated similar trends in primary and secondary outcomes compared with the overall analysis. CONCLUSIONS: REC was an effective and safe surgical approach for I-IPBD compared with SEC, thus it should be recommended routinely for these patients.
引用
- Yang CZ, Zhu CZ, Chen ZY, et al. The Efficacy and Safety of Intrapancreatic Bile Duct Resection Applied in Type I of Congenital Bile Duct Dilation: A Multicenter Control Cohort Study. Ann Surg. 2025. PMID: 40794433. doi:10.1097/SLA.0000000000006898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。